ESC 365 - Inotropes or inodilators in HFrEF: what to use, on whom, when and how? Therapeutic needs.

HFA Premium Access

Inotropes or inodilators in HFrEF: what to use, on whom, when and how? Therapeutic needs.

Session: Inotropes or inodilators in HFrEF: what to use, on whom, when and how?

Topic: Pharmacotherapy

Speaker: Professor V. Harjola (Helsinki, FI)

Sponsored by Orion Pharma

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Professor Veli-Pekka Harjola

Helsinki University Hospital, Helsinki (Finland)

29 presentations

0 follower

2 more presentations in this session

Inotropes or inodilators in HFrEF: what to use, on whom, when and how? What is available?

Speaker: Professor Z. Papp (Debrecen, HU)

Inotropes or inodilators in HFrEF: what to use, on whom, when and how? Clinical practice.

Speaker: Doctor J. Parissis (Athens, GR)

Access the full session

Inotropes or inodilators in HFrEF: what to use, on whom, when and how?

Speakers: Professor V. Harjola, Professor Z. Papp, Doctor J. Parissis

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources